Beta-blocking in heart failure patients: Balancing the evidence

International Journal of Cardiology

Volumn 79, Issue 1, 2001, Pages 5-12

  Marinone, Maria Gabriella ^b   Al Nasser, Faisal ^a   Francis, Darrel ^a   Piepoli, Massimo F ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Ospedale Civile Polichirurgico   (Italy)

Author keywords

Beta blockers; Heart failure

Indexed keywords

ACEBUTOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LABETALOL; METOPROLOL; NEBIVOLOL;

BETA ADRENERGIC RECEPTOR BLOCKING; DATA BASE; DRUG EFFECT; DRUG EFFICACY; EXERCISE TOLERANCE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; LUNG CAPILLARY PRESSURE; MORTALITY; PRIORITY JOURNAL; REVIEW; STROKE; TREATMENT OUTCOME;

EID: 0034993749     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(01)00397-7     Document Type: Editorial

References (56)

1. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure. The EPICAL Study
2. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy
3. Diastolic perfusion time at ischemic threshold in patients with stress-induced ischemia
4. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure
5. Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy
6. A case of dilated cardiomyopathy in which the effect of beta-blocker therapy was clearly demonstrated by 123I-MIBG scintigraphy
7. Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol
8. Beneficial effects of metoprolol treatment in congestive heart failure. Reversal of sympathetic-induced alterations of immunologic function
9. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect
10. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy
11. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy
12. Randomised, placebo-controlled trial of carvediolo in patients with congestive heart failure due to ischaemic heart failure
13. Exercise testing and training with beta-adrenergic blockade: Role of drug washout period in 'unmasking' a training effect
14. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
15. A randomised trail of b-blockade in heart failure
16. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators
17. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
18. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomised trial
19. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
20. Effect of beta-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials
21. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure
22. The epidemiology of heart failure: The Framingham Study
23. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
24. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: Design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study
25. Tolerability and efficacy of carvedilol in patients with New York Heart Association Class IV heart failure
26. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: A multi-institutional experience
27. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: A double-blind, randomized, placebo-controlled trial
28. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy
29. Idiopathic dilated cardiomyopathy among Swedish patients with congestive heart failure
30. Hemodynamic effects of celiprolol in patients with ischemic and non-ischemic cardiomyopathy
31. Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint
32. Waagstein F Recovery from left ventricular asynergy in ischemic cardiomyopathy following long-term beta blockade treatment
33. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy
34. The Cardiac Insufficieny Bisoprolol Study II (Letter)
35. Eng C Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure
36. Double blind, placebo controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE trial
37. Guidelines for the evaluation and management of heart failure
38. Introducing new treatments in clinical practice: The Italian approach to beta-blockers in heart failure
39. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy
40. A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy
41. Improvement in exercise performance and hemodynamics by labetalol in patients with idiopathic dilated cardiomyopathy
42. Usefulness of bucindolol in congestive heart failure
43. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo
44. Pilot study of cardiovascular effects of nebivolol in congestive heart failure
45. D'Onofrio F Metabolic and cardiovascular benefits deriving from beta-adrenergic blockade in chronic congestive heart failure
46. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure
47. Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study
48. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy
49. Beneficial effects of metoprolol in heart failure associated with coronary artery disease: A randomized trial
50. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
51. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators
52. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
53. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure
54. Carvedilol efficacy in severe heart failure